HBME–1, CD15 and p53 Protein Expression in Thyroid Carcinoma and their Significance in Diagnosis

REFERENCES

1. ↵
   1. Christopher D M Fletcher

   . Diagnostic histopathology of tumors, 2nd. Churchill Livingstone, 2000; 963.
2. ↵
   1. Livolsi VA.

   Surgical pathology of the thyroid. WB Saunders company, 1990;131.
3. ↵
   1. Scopa CD,
   2. Melachrinou M,
   3. Saradopoulou C, et al.

   The significance of the grooved nucleus in thyroid lesions. Mod Pathol, 1993; 6:691–694.

   OpenUrlPubMedWeb of Science
4. ↵
   1. Miettinen M,
   2. Karkkainen P.

   Differential reactivity of HBME–1 and CD15 antibodies in benign and malignant thyroid tumors. Preferential reactivity with malignant tumours. Virchows Arch, 1996;429:213–219.

   OpenUrlPubMedWeb of Science
5. ↵
   1. Pollina L,
   2. Pacini F,
   3. Fontanini G, et al.

   bcl–2, p53 and proliferating cell nuclear antigen expression is related to the degree of differentiation in thyroid carcinomas. Br J Cancer, 1996; 73:139–143.

   OpenUrlPubMedWeb of Science
6. ↵
   1. Kilicarslan B,
   2. Pesterelli EH,
   3. Oren N, et al.

   Epithelial membrane antigen and S–100 protein expression in benign and malignant papillary thyroid neoplasma. Adv Clin Path, 2000; 4:155–158.

   OpenUrlPubMed
7. ↵
   1. Mai KT,
   2. Landry DC,
   3. Thomas J, et al.

   Follicular adenoma with papillary architecture; a lesion mimicking papillary thyroid carcinoma. Histopathology, 2001;39:25–32.

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   1. Cheung CC,
   2. Ezzat S,
   3. Freeman JL, et al.

   Immunohistochemical diagnosis of papillary thyroid carcinoma. Mod Pathol, 2001;14:338–342.

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   1. Ordonez NG.

   The immunohistochemical diagnosis of malignant mesothelioma. Differention of mesothelioma and lung adenocarcinoma. Am J Surg Pathol, 1989;13:276–291.

   OpenUrlPubMedWeb of Science
10. ↵
    1. Schroder S,
    2. Schwarz W,
    3. Rehpenning W, et al.

    Prognostic significance of Leu–M1 immunostaining in papillary carcinomas of the thyroid gland. Virchows Arch A Pathol Anat Histopathol, 1987;411:435–439.

    OpenUrlCrossRefPubMed
11. ↵
    1. Shahedian B,
    2. Shi Y,
    3. Zou M, et al.

    Thyroid carcinoma is characterized by genomic instability: evidence from p53 mutations. Mol Genet Metab, 2001; 72:155–163.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    1. Dobashi Y,
    2. Sakamoto A,
    3. Sugimura H, et al.

    Over expression of p53 as a possible prognostic factor in human thyroid carcinoma. Am J Surg Pathol, 1993;17:375–381.

    OpenUrlCrossRefPubMedWeb of Science